ID

12998

Description

Randomized Trial of Follow-up Strategies in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00156039

Lien

https://clinicaltrials.gov/show/NCT00156039

Mots-clés

  1. 10/01/2016 10/01/2016 -
Téléchargé le

10 janvier 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00156039

Eligibility Breast Cancer NCT00156039

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
women with breast cancer on well follow-up at regional cancer centres in ontario and manitoba
Description

Gender, breast cancer, follow up

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0678222
UMLS CUI [3]
C1522577
diagnosed at least 12 months previously (range 9-15 months)
Description

date of diagnosis

Type de données

boolean

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C1274082
without evidence of active disease (i.e., stages iiib and iv excluded)
Description

no active disease

Type de données

boolean

Alias
UMLS CUI [1]
C2707252
free from any primary treatment complications
Description

treatment complications

Type de données

boolean

Alias
UMLS CUI [1]
C0679861
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
primary treatment at least 3 months previously, except for continued use of tamoxifen
Description

primary treatment date, tamoxifen

Type de données

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0011008
UMLS CUI [2]
C0039286
still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
Description

complications of primary treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0679861
UMLS CUI [2]
C1708063
unable to identify an acceptable family physician to provide follow-up
Description

family physician to provide follow-up

Type de données

boolean

Alias
UMLS CUI [1]
C1522577
language or literacy skills inconsistent with completing questionnaires
Description

language

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1145677
unable to comply with study protocol including completion of questionnaires
Description

unable to comply

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
Description

study participation status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
actively followed at a cancer centre for another primary cancer
Description

malignancies

Type de données

boolean

Alias
UMLS CUI [1]
C0006826

Similar models

Eligibility Breast Cancer NCT00156039

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender, breast cancer, follow up
Item
women with breast cancer on well follow-up at regional cancer centres in ontario and manitoba
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C1522577 (UMLS CUI [3])
date of diagnosis
Item
diagnosed at least 12 months previously (range 9-15 months)
boolean
C2316983 (UMLS CUI [1,1])
C1274082 (UMLS CUI [1,2])
no active disease
Item
without evidence of active disease (i.e., stages iiib and iv excluded)
boolean
C2707252 (UMLS CUI [1])
treatment complications
Item
free from any primary treatment complications
boolean
C0679861 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
primary treatment date, tamoxifen
Item
primary treatment at least 3 months previously, except for continued use of tamoxifen
boolean
C1708063 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
complications of primary treatment
Item
still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
boolean
C0679861 (UMLS CUI [1])
C1708063 (UMLS CUI [2])
family physician to provide follow-up
Item
unable to identify an acceptable family physician to provide follow-up
boolean
C1522577 (UMLS CUI [1])
language
Item
language or literacy skills inconsistent with completing questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1145677 (UMLS CUI [1,3])
unable to comply
Item
unable to comply with study protocol including completion of questionnaires
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
study participation status
Item
previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
boolean
C2348568 (UMLS CUI [1])
malignancies
Item
actively followed at a cancer centre for another primary cancer
boolean
C0006826 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial